Three-month results showed 80% of patients with chronic back pain treated with DTM Spinal Cord Stimulation reported at least 50% pain relief, compared with 51% of patients treated with conventional SCS, as measured by the Visual Analog Scale (VAS), a widely used and accepted measure for pain intensity.1 Fifty-percent pain relief, as measured by VAS, is a recognized industry standard to define minimum therapy success.
This funding will enable RetiSpec to accelerate the commercialization of its groundbreaking technology aimed at early detection of Alzheimer's disease.
